Article
A Novel PDZRN3::BRAF Fusion as Potential Driver Mechanism in BAP1-inactivated Melanocytoma.
The American Journal of dermatopathology - 1 Jul 2026
Yu Yanhong, Sabljic Thomas, Capo-Chichi Jose-Mario, Kamil Zaid Saeed
Abstract excerpt
ABSTRACT: BAP1 (BRCA 1-associated protein 1)-inactivated melanocytic tumor (BIMT) is a melanocytic neoplasm characterized histologically by large epithelioid cells and is commonly associated with a conventional nevus component. The defining molecular alteration is inactivation of the BAP1 gene. Initiating mutations in BIMT include BRAF p.V600E, or less commonly RAS mutations and fusions involving RAF1 . In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
